Adherence To The Inhaled Antibiotic Treatment In Patients With Cystic Fibrosis

被引：0

作者：

Sole, A. ^{[1
]}

Gartner, S. ^{[2
]}

Alvarez, A. ^{[2
]}

Pastor, M. ^{[3
]}

Baranda, F. ^{[4
]}

Giron, R. ^{[5
]}

Martinez, M. ^{[6
]}

Prados, C. ^{[7
]}

Maiz, L. ^{[8
]}

Oliva, C. ^{[9
]}

Gonzalez, M. ^{[10
]}

机构：

[1] Univ Hosp La Fe, Valencia, Spain

[2] Vall dHebron Univ Hosp, Barcelona, Spain

[3] Virgen de la Arrixaca Univ Hosp, Murcia, Spain

[4] Cruces Univ Hosp, Baracaldo, Spain

[5] La Princesa Univ Hosp, Madrid, Spain

[6] 12 Octubre Univ Hosp, Madrid, Spain

[7] La Paz Univ Hosp, Madrid, Spain

[8] Ramon y Cajal Univ Hosp, Madrid, Spain

[9] Virgen Candelaria Univ Hosp, San Cristobal la Laguna, Spain

[10] Nino Jesus Hosp, Madrid, Spain

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2013年 / 187卷

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A4358

引用

页数：1

共 50 条

[21] Association between the introduction of a new cystic fibrosis inhaled antibiotic class and change in prevalence of patients receiving multiple inhaled antibiotic classes
Dasenbrook, Elliott C.
Konstan, Michael W.
VanDevanter, Donald R.
JOURNAL OF CYSTIC FIBROSIS, 2015, 14 (03) : 370 - 375
[22] Technological and behavioral strategies to reduce treatment burden and improve adherence to inhaled antibiotics in cystic fibrosis
Geller, David E.
Madge, Susan
RESPIRATORY MEDICINE, 2011, 105 : S24 - S31
[23] Specificity of cystic fibrosis: inhaled treatment education
Marais, P
REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE, 1999, 39 (08): : 709 - 710
[24] Long-term effect of chronic intravenous and inhaled nephrotoxic antibiotic treatment on the renal function of patients with cystic fibrosis
Florescu, Marius C.
Lyden, Elizabeth
Murphy, Peter J.
Florescu, Diana F.
Fillaus, Jennifer
HEMODIALYSIS INTERNATIONAL, 2012, 16 (03) : 414 - 419
[25] Novel inhaled combined antibiotic formulations in the treatment of Pseudomonas aeruginosa airways infections in cystic fibrosis
Antoniu, Sabina
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2015, 13 (07) : 897 - 905
[26] Adherence to tobramycin inhaled powder vs inhaled solution in patients with cystic fibrosis: analysis of US insurance claims data
Hamed, Kamal
Conti, Valentino
Tian, Hengfeng
Loefroth, Emil
PATIENT PREFERENCE AND ADHERENCE, 2017, 11 : 831 - 838
[27] Pharmacokinetics of inhaled colistin in patients with cystic fibrosis
Ratjen, F
Rietschel, E
Kasel, D
Schwiertz, R
Starke, K
Beier, H
van Koningsbruggen, S
Grasemann, H
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (02) : 306 - 311
[28] USE OF INHALED TOBRAMYCIN IN PATIENTS WITH CYSTIC FIBROSIS
Chermensky, A. G.
Gembitskaya, M. E.
TERAPEVTICHESKII ARKHIV, 2010, 82 (08) : 76 - 78
[29] SAFETY OF INHALED TOBRAMYCIN IN PATIENTS WITH CYSTIC FIBROSIS
McColley, S.
Rietschel, E.
Brockhaus, F.
Angyalosi, G.
Higgins, M.
PEDIATRIC PULMONOLOGY, 2011, : 344 - 344
[30] Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis
Dawson, Sophie
Girling, Carla-Jane
Cowap, Lisa
Clark-Carter, David
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (03):

← 1 2 3 4 5 →